266 related articles for article (PubMed ID: 15268897)
1. FGF23 is processed by proprotein convertases but not by PHEX.
Benet-Pagès A; Lorenz-Depiereux B; Zischka H; White KE; Econs MJ; Strom TM
Bone; 2004 Aug; 35(2):455-62. PubMed ID: 15268897
[TBL] [Abstract][Full Text] [Related]
2. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
Quarles LD
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
[TBL] [Abstract][Full Text] [Related]
3. The wrickkened pathways of FGF23, MEPE and PHEX.
Rowe PS
Crit Rev Oral Biol Med; 2004 Sep; 15(5):264-81. PubMed ID: 15470265
[TBL] [Abstract][Full Text] [Related]
4. Function of PHEX mutations p.Glu145* and p.Trp749Arg in families with X-linked hypophosphatemic rickets by the negative regulation mechanism on FGF23 promoter transcription.
Gan YM; Zhang YP; Ruan DD; Huang JB; Zhu YB; Lin XF; Xiao XP; Cheng Q; Geng ZB; Liao LS; Tang FQ; Luo JW
Cell Death Dis; 2022 Jun; 13(6):518. PubMed ID: 35654784
[TBL] [Abstract][Full Text] [Related]
5. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.
Rowe PS
Crit Rev Eukaryot Gene Expr; 2012; 22(1):61-86. PubMed ID: 22339660
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of PHEX Mutations and FGF23 Profiles in a Taiwanese Cohort With X-Linked Hypophosphatemia Including 102 Patients.
Su PH; Yu JS; Wu YZ; Tsai YS; Lo FS; Lin JL; Chao MC; Hsu CC; Ke YY; Chiu PC; Chen JC; Huang YH; Lin SP; Chou YY; Ting WH; Wang SY; Chiu CF; Huang YC; Hsiao HP; Lin CH; Wang CH; Bau DT; Lin CY
In Vivo; 2024; 38(1):341-350. PubMed ID: 38148081
[TBL] [Abstract][Full Text] [Related]
7. Familial hypophosphatemic rickets caused by a large deletion in PHEX gene.
Saito T; Nishii Y; Yasuda T; Ito N; Suzuki H; Igarashi T; Fukumoto S; Fujita T
Eur J Endocrinol; 2009 Oct; 161(4):647-51. PubMed ID: 19581284
[TBL] [Abstract][Full Text] [Related]
8. Three novel mutations of the PHEX gene in three Chinese families with X-linked dominant hypophosphatemic rickets.
Xia W; Meng X; Jiang Y; Li M; Xing X; Pang L; Wang O; Pei Y; Yu LY; Sun Y; Hu Y; Zhou X
Calcif Tissue Int; 2007 Dec; 81(6):415-20. PubMed ID: 18046499
[TBL] [Abstract][Full Text] [Related]
9. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
[TBL] [Abstract][Full Text] [Related]
10. A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.
Ichikawa S; Austin AM; Gray AK; Econs MJ
J Bone Miner Res; 2012 Feb; 27(2):453-60. PubMed ID: 22006791
[TBL] [Abstract][Full Text] [Related]
11. FGF23 and disorders of phosphate homeostasis.
Yu X; White KE
Cytokine Growth Factor Rev; 2005 Apr; 16(2):221-32. PubMed ID: 15863037
[TBL] [Abstract][Full Text] [Related]
12. A novel c.2179T>C mutation blocked the intracellular transport of PHEX protein and caused X-linked hypophosphatemic rickets in a Chinese family.
Li B; Wang X; Hao X; Liu Y; Wang Y; Shan C; Ao X; Liu Y; Bao H; Li P
Mol Genet Genomic Med; 2020 Aug; 8(8):e1262. PubMed ID: 32511895
[TBL] [Abstract][Full Text] [Related]
13. Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23.
White KE; Carn G; Lorenz-Depiereux B; Benet-Pages A; Strom TM; Econs MJ
Kidney Int; 2001 Dec; 60(6):2079-86. PubMed ID: 11737582
[TBL] [Abstract][Full Text] [Related]
14. FGF23 and its role in X-linked hypophosphatemia-related morbidity.
Beck-Nielsen SS; Mughal Z; Haffner D; Nilsson O; Levtchenko E; Ariceta G; de Lucas Collantes C; Schnabel D; Jandhyala R; Mäkitie O
Orphanet J Rare Dis; 2019 Feb; 14(1):58. PubMed ID: 30808384
[TBL] [Abstract][Full Text] [Related]
15. Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia.
Feng JQ; Clinkenbeard EL; Yuan B; White KE; Drezner MK
Bone; 2013 Jun; 54(2):213-21. PubMed ID: 23403405
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of patients with FGF23-related hypophosphatemic rickets.
Kinoshita Y; Saito T; Shimizu Y; Hori M; Taguchi M; Igarashi T; Fukumoto S; Fujita T
Eur J Endocrinol; 2012 Aug; 167(2):165-72. PubMed ID: 22577109
[TBL] [Abstract][Full Text] [Related]
17. A novel Phex mutation in a new mouse model of hypophosphatemic rickets.
Owen C; Chen F; Flenniken AM; Osborne LR; Ichikawa S; Adamson SL; Rossant J; Aubin JE
J Cell Biochem; 2012 Jul; 113(7):2432-41. PubMed ID: 22573557
[TBL] [Abstract][Full Text] [Related]
18. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.
Liu S; Guo R; Simpson LG; Xiao ZS; Burnham CE; Quarles LD
J Biol Chem; 2003 Sep; 278(39):37419-26. PubMed ID: 12874285
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic role of Fgf23 in Hyp mice.
Liu S; Zhou J; Tang W; Jiang X; Rowe DW; Quarles LD
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E38-49. PubMed ID: 16449303
[TBL] [Abstract][Full Text] [Related]
20. Post-translational modification of Fibroblast Growth Factor 23.
Fukumoto S
Ther Apher Dial; 2005 Aug; 9(4):319-22. PubMed ID: 16076374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
